Anneyd Avalos-Pena
Internal Medicine · Doral, FLNPI 1962863266
Payments from drug & device makers
Across 358 payments — averaging $4197.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mylan Pharmaceuticals Inc.$586K
- E.r. Squibb & Sons, L.L.C.$204K
- Novartis$159K
- Amgen$156K
- Astrazeneca UK Limited$135K
- Modernatx, Inc.$105K
- plus $158K from 44 others
What the payments were for
- Travel & lodging$2814%
- Food & beverage$6,20896%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,502,781 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Doral
- Luis MartinezDoral$13.8M
- Jorge VenereoDoral$4.4M
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
- Jaynier MoyaPembroke Pines$45.4M
- Mark KutnerMiami$35.7M
- Gilberto JimenezHialeah$35.6M
- Mira BaronWest Palm Beach$29.6M
- William SanchezHialeah$28.9M
- Nelia Sanchez-CrespoHollywood$28.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.